- Independent doctor
The London Neuropsychiatry Clinic
Assessment report published 21 October 2025
Contents
Ratings
Our view of the service
Date of Assessment: 5 and 6 August 2025.
The London Neuropsychiatry Clinic is an independent service delivering community mental health interventions. The London Neuropsychiatry Clinic is delivered by a single Neuropsychiatrist; Dr Bodani, and their personal assistant. The London Neuropsychiatry Clinic provides a neuropsychiatry consultation service with referrals from GP’s and other consultants, brain injury case managers or self-referrals from patients.
Following this assessment, the location was rated as good.
The London Neuropsychiatry Clinic registered with the Care Quality Commission in May 2024 to provide treatment of disease, disorder or injury.
Consultations are offered either face to face at 96 Harley Street London, or where necessary remotely using secure digital platforms.
This is our initial comprehensive inspection of the service. We rated it as good overall.
We found several areas of good practice:
Staff delivered person-centred care and developed tailored services in partnership with people.
Staff developed holistic, recovery-oriented care plans informed by a comprehensive assessment.
Staff treated patients with compassion and kindness and understood the individual needs of patients. They actively engaged patients in decisions about their care, ensuring that planning was collaborative and person-centred.
Patients told us that their experience was prompt and supportive, and reasonable adjustments were made according to need.
We found some areas for improvement:
The administrative staff supported the triage of patients and spoke to patients regularly about their medication, wellbeing and at times during deteriorating mental health.
The Multi-Disciplinary Team meeting minutes did not reflect whether the Neuropsychiatrist was discussing the choice of preparation, dose and follow up arrangements as part of the review.
The service did not carry out patient records and prescribing audits to ensure safe prescribing was taking place.
The prescribing policies did not contain information about inclusion, and exclusion criteria for cannabis based medicinal products (CBPMs).
Patients could give feedback on the service, via the provider website, however there was no formal and regular mechanism to obtain feedback consistently to help improve the service.